InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

TK

Tang, Kevin

OFFICER

Aurinia Pharmaceuticals Inc.

累计流向

0

申报总数

0

公司

€775万

▲ 买入（10 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

10

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the complete record of transactions filed by Tang, Kevin. Director active across 1 company, notably Aurinia Pharmaceuticals Inc.. In total, 15 filings have been recorded. Breakdown: 10 buys · 0 sell. Total volume traded: €7.7m. History available since 29 May 2026. The latest transaction was disclosed on 2 June 2026 (70 - Acquisition or disposition (writing) of third party derivative). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Tang, Kevin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Aurinia Pharmaceuticals Inc. (US)

申报15 总计

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月2日Aurinia Pharmaceuticals Inc.

CA$8,2500SEDI ↗

5,000 股@ CA$1.650.0002% mcap0.1% 占其流量OptionsTSXSEDI:4728385

标准退出：2026年8月31日 (T+90)

●

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2024年9月12日Aurinia Pharmaceuticals Inc.

OptionsTSXSEDI:4728383

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月2日Aurinia Pharmaceuticals Inc.

CA$8,25023SEDI ↗

5,000 股@ CA$1.650.0002% mcap0.1% 占其流量OptionsTSXSEDI:4728381

标准退出：2026年8月31日 (T+90)

●

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2024年9月12日Aurinia Pharmaceuticals Inc.

OptionsTSXSEDI:4728241

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月2日Aurinia Pharmaceuticals Inc.

CA$157万29SEDI ↗

103,002 股@ CA$15.280.046% mcap12.6% 占其流量Common SharesTSXSEDI:4728152

标准退出：2026年8月31日 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月1日Aurinia Pharmaceuticals Inc.

CA$75221SEDI ↗

49 股@ CA$15.340.0000% mcap0.0% 占其流量Common SharesTSXSEDI:4728150

标准退出：2026年8月30日 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月1日Aurinia Pharmaceuticals Inc.

CA$262万29SEDI ↗

171,760 股@ CA$15.280.077% mcap21.1% 占其流量Common SharesTSXSEDI:4728147

标准退出：2026年8月30日 (T+90)

●

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2024年9月12日Aurinia Pharmaceuticals Inc.

Common SharesTSXSEDI:4728145

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月2日Aurinia Pharmaceuticals Inc.

CA$157万29SEDI ↗

103,003 股@ CA$15.280.046% mcap12.6% 占其流量Common SharesTSXSEDI:4728143

标准退出：2026年8月31日 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月1日Aurinia Pharmaceuticals Inc.

CA$76721SEDI ↗

50 股@ CA$15.340.0000% mcap0.0% 占其流量Common SharesTSXSEDI:4728142

标准退出：2026年8月30日 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月1日Aurinia Pharmaceuticals Inc.

CA$262万29SEDI ↗

171,761 股@ CA$15.280.077% mcap21.1% 占其流量Common SharesTSXSEDI:4728141

标准退出：2026年8月30日 (T+90)

●

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年5月29日Aurinia Pharmaceuticals Inc.

50,000 股Common SharesTSXSEDI:4728140

●

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年5月29日Aurinia Pharmaceuticals Inc.

50,000 股Common SharesTSXSEDI:4728137

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年5月29日Aurinia Pharmaceuticals Inc.

CA$402万27SEDI ↗

262,682 股@ CA$15.310.12% mcap32.3% 占其流量Common SharesTSXSEDI:4728134

标准退出：2026年8月27日 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年5月29日Aurinia Pharmaceuticals Inc.

CA$35,29017SEDI ↗

2,299 股@ CA$15.350.0010% mcap0.3% 占其流量Common SharesTSXSEDI:4728128

标准退出：2026年8月27日 (T+90)

15 条申报中的 15 条

About Tang, Kevin

Tang, Kevin is an insider at Aurinia Pharmaceuticals Inc. (XNAS), where he is 4 - Director of Issuer, 5 - Senior Officer of Issuer. He has 15 filings in total, and across the sampled recent filings there were buys totaling EUR 7747370, with no sales, over the period from 2026-06-03 to 2026-06-03.